相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insights into the modulation of the interferon response and NAD+ in the context of COVID-19
Nada J. Habeichi et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2022)
The Key Role of NAD+ in Anti-Tumor Immune Response: An Update
Fabio Morandi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma
Fatih M. Uckun
CANCERS (2021)
NAD+ Metabolism, Metabolic Stress, and Infection
Benjamin Groth et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
NAD+ homeostasis in human health and disease
Ruben Zapata-Perez et al.
EMBO MOLECULAR MEDICINE (2021)
The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression
Long Gao et al.
CELL DEATH & DISEASE (2021)
NAD+-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin
Dong-Jie Li et al.
THERANOSTICS (2021)
CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
Alberto L. Horenstein et al.
FRONTIERS IN IMMUNOLOGY (2019)
Resolving the topological enigma in Ca2+ signaling by cyclic ADP-ribose and NAADP
Hon Cheung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Implications of altered NAD metabolism in metabolic disorders
Keisuke Okabe et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Metabolic Reprogramming via Targeting CD38 NADase Augments Adoptive T Cell Therapy
Mario R. Fernandez et al.
CELL METABOLISM (2018)
CD38-NAD(+)Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response
Shilpak Chatterjee et al.
CELL METABOLISM (2018)
Immunomodulatory effects of CD38-targeting antibodies
Niels W. C. J. van de Donk
IMMUNOLOGY LETTERS (2018)
The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging
Eduardo N. Chini et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
Limo Chen et al.
CANCER DISCOVERY (2018)
CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
Fabio Morandi et al.
FRONTIERS IN IMMUNOLOGY (2018)
CD38 antibodies in multiple myeloma: back to the future
Niels W. C. J. van de Donk et al.
BLOOD (2018)
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
Jakub Krejcik et al.
BLOOD (2016)
CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism
Juliana Camacho-Pereira et al.
CELL METABOLISM (2016)
Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
Niels W. C. J. van de Donk et al.
IMMUNOLOGICAL REVIEWS (2016)
The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor-Mediated Cross-Linking
Marije B. Overdijk et al.
JOURNAL OF IMMUNOLOGY (2016)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama et al.
NATURE COMMUNICATIONS (2016)
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38
J. David Becherer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors
Curt D. Haffner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences
Xiao-Hong Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
Linn Fagerberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
CD38 and CD157: A long journey from activation markers to multifunctional molecules
Valeria Quarona et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38 Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome
Carlos Escande et al.
DIABETES (2013)
CD39 and CD73 in immunity and inflammation
Luca Antonioli et al.
TRENDS IN MOLECULAR MEDICINE (2013)
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
Alberto L. Horenstein et al.
ONCOIMMUNOLOGY (2013)
ATP and ADP hydrolysis in cell membranes from rat myometrium
Maja Milosevic et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Insights into the Mechanism of Bovine CD38/NAD+Glycohydrolase from the X-Ray Structures of Its Michaelis Complex and Covalently-Trapped Intermediates
Pascal F. Egea et al.
PLOS ONE (2012)
Age-Associated Changes In Oxidative Stress and NAD+ Metabolism In Human Tissue
Hassina Massudi et al.
PLOS ONE (2012)
Design, synthesis and biological characterization of novel inhibitors of CD38
Min Dong et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2011)
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2
Angela J. Russell et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
CD38 as a Regulator of Cellular NAD: A Novel Potential Pharmacological Target for Metabolic Conditions
Eduardo Nunes Chini
CURRENT PHARMACEUTICAL DESIGN (2009)
Mechanism of Cyclizing NAD to Cyclic ADP-ribose by ADP-ribosyl Cyclase and CD38
Richard Graeff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Structural basis for formation and hydrolysis of the calcium messenger cyclic ADP-ribose by human CD38
Qun Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Structure and enzymatic functions of human CD38
Hon Cheung Lee
MOLECULAR MEDICINE (2006)
Structural basis for the mechanistic understanding of human CD38-controlled multiple catalysis
Qun Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine nicotinic acid adenine dinucleotide phosphate (NAADP) synthesis and hydrolysis activities
Richard Graeff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Crystal structure of human CD38 extracellular domain
Q Liu et al.
STRUCTURE (2005)
Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes
DBR Leal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2005)
The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells
GG Yegutkin et al.
BIOCHEMICAL JOURNAL (2002)
分享论文
